KLRA
Kailera Therapeutics, Inc.
11.20$
-6.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Kailera Therapeutics, Inc. (KLRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -120 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2025 |
|---|---|
| -120 | |
| 0.3 | |
| 11 | |
| 17 | |
| 2.1 | |
| -493 | |
| 100 | |
| 599 | |
| -14 | |
| -122 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.